Is There a Best Approach to Treating Women with Symptomatic Leiomyomas?
Women's Health Summary and Comment
Hysterectomy provided the most relief at 12 months, but myomectomy and uterine artery embolization also were effective.
By Robert W. Rebar, MD
September 23, 2010
Covering:
Spies JB et al., Obstet Gynecol 2010 Sep; 116:641
Patient Satisfaction with Therapeutic Options for Heavy Menstrual Bleeding
Women's Health Summary and Comment
Most women are satisfied with endometrial ablation or the levonorgestrel-releasing intrauterine system; hysterectomy remains the definitive treatment for heavy menstrual bleeding.
By Wendy S. Biggs, MD
September 16, 2010
Covering:
Middleton LJ et al., BMJ 2010 Aug 16; 341:c3929
Levonorgestrel-Releasing Intrauterine System Lightens Heavy Menstrual Bleeding
Women's Health Summary and Comment
The LNG-IUS was more effective than oral medroxyprogesterone acetate.
By Robert W. Rebar, MD
September 16, 2010
Covering:
Kaunitz AM et al., Obstet Gynecol 2010 Sep; 116:625
Bones Needs Energy, Too
Female adolescent runners with markers of elevated bone turnover had a metabolic profile consistent with energy deficiency.
Onset of Puberty: Younger Still
At age 7 years, 10% of white girls, 23% of black girls, and 15% of Hispanic girls had evidence of breast development.
Depot Medroxyprogesterone Acetate Injections at the Pharmacy Might Be a Good Option
Women's Health Summary and Comment
Acceptability and low continuation rates for DMPA were similar whether women received injections at a pharmacy or a family planning clinic.
Does Estrogen-Only Hormone Therapy Affect Risk for Lung Cancer?
Women's Health Summary and Comment
WHI data indicate that use of estrogen-only HT was not associated with lung cancer incidence or mortality.
By Andrew M. Kaunitz, MD
September 2, 2010
Covering:
Chlebowski RT et al., J Natl Cancer Inst 2010 Aug 13
Lose a Little Weight, Gain Some Continence
Women's Health Summary and Comment
Free
Weight loss between 5% and 10% of body weight was associated with significantly improved urinary incontinence in overweight and obese women.
By Wendy S. Biggs, MD
August 26, 2010
Covering:
Wing RR et al., Obstet Gynecol 2010 Aug; 116:284
Vaginal Mesh for Pelvic Organ Prolapse: Worth the Risks?
Women's Health Summary and Comment
Short-term findings from a randomized trial suggest the answer is no.
By Andrew M. Kaunitz, MD , and Brent E. Seibel, MD
August 19, 2010
Covering:
Iglesia CB et al., Obstet Gynecol 2010 Aug; 116:293
Intensive Program Cuts Hot Flashes Along with Weight
Women's Health Summary and Comment
Part — but not all — of the improvement was explained by effects on weight-related parameters.
Fighting Warts with Wart Vaccine
Dermatology Summary and Comment
Repeat vaccinations appeared to provide effective treatment of early vulvar intraepithelial neoplasia with small lesions.
By Mark V. Dahl, MD
August 13, 2010
Covering:
Welters MJP et al., Proc Natl Acad Sci U S A 2010 Jun 29; 107:11895
Managing Menopausal Symptoms in Breast Cancer Survivors: Experience from an Australian Clinic
Women's Health Summary and Comment
Breast cancer survivors benefit from multidisciplinary-based treatment for severe menopausal symptoms.
Autoimmune Encephalopathy in Children and Adults With and Without Cancer
Neurology Summary and Comment
A study of diagnosis and clinical course of <$EMPH_O>N<$EMPH_C>-methyl-D-aspartate receptor antibody–associated encephalopathy.
By Richard J. Caselli, MD
August 3, 2010
Covering:
Irani SR et al., Brain 2010 Jun; 133:1655
Cellular Angiofibromas: The Meaning of Sarcomatous Transformation
Dermatology Summary and Comment
Few patients with atypia or sarcomatous changes experienced recurrent CAF.
By Angelica Selim, MD
July 30, 2010
Covering:
Chen E and Fletcher CD., Am J Surg Pathol 2010 May; 34:707
The First Reproductive Health Visit for Girls: Who, What, When, Where, and Why?
The American College of Obstetricians and Gynecologists recommends that a girl's first reproductive health care visit to a gynecologist should occur at age 13–15 years.
By Alain Joffe, MD, MPH, FAAP
July 21, 2010
Covering:
The American College of Obstetricians and Gynecologists., Obstet Gynecol 2010 Jul; 116:240
Physicians' Beliefs About Pap Screening Intervals
General Medicine Summary and Comment
Poor adherence to guidelines and differences among specialties were noted.
By Thomas L. Schwenk, MD
July 13, 2010
Covering:
Saraiya M et al., Arch Intern Med 2010 Jun 14; 170:977
Sawaya GF., Arch Intern Med 2010 Jun 14; 170:985
Gender Matters in the Course of Bipolar Illness
Psychiatry Summary and Comment
Higher rates of both rapid cycling and anxiety disorders among bipolar women help to account for their greater rates of depression.
By Joel Yager, MD
July 2, 2010
Covering:
Altshuler LL et al., Am J Psychiatry 2010 Jun; 167:708
Reluctance to Lengthen Pap Testing Intervals
Women's Health Summary and Comment
Free
Fewer than 20% of physicians would extend cervical cancer screening intervals to
By Wendy S. Biggs, MD
July 1, 2010
Covering:
Saraiya M et al., Arch Intern Med 2010 Jun 14; 170:977
Sawaya GF., Arch Intern Med 2010 Jun 14; 170:985
Hastening Chlamydia Therapy
Women's Health Summary and Comment
Electronic medical records shortened time-to-treat interval.
By Anna Wald, MD, MPH
July 1, 2010
Covering:
Brook MG et al., Sex Transm Infect 2010 May 21
Don't Reinfect the Messenger: Partner-Delivered Therapy and Trichomoniasis Prevention
Women's Health Summary and Comment
Offering women antibiotics for their male partners can be effective for lowering reinfection rates.
By Anna Wald, MD, MPH
July 1, 2010
Covering:
Schwebke JR and Desmond RA., Sex Transm Dis 2010 Jun; 37:392
Is the Pill Less Effective in Obese Women?
Women's Health Summary and Comment
Free
A pharmacokinetic study suggests the answer is no.
Does Depot Medroxyprogesterone Block Ovulation in Extremely Obese Women?
Women's Health Summary and Comment
Obese women did not ovulate >1 week after receiving DMPA, but some showed evidence of follicular development.
By Robert W. Rebar, MD
June 24, 2010
Covering:
Segall-Gutierrez P et al., Contraception 2010 Jun; 81:487
For U.S. Women, It's Still the Pill
Women's Health Summary and Comment
Oral contraceptive pills remain the most common method of contraception, followed by female sterilization.
CDC Guidance on Contraception for Women with Medical Conditions
Women's Health Practice Watch
Free
Medical eligibility criteria for rating the safety of prescription contraceptive methods in women with specific medical conditions
Uterine Artery Embolization Doesn't Raise Risk for Ovarian Failure Within 1 Year
Women's Health Summary and Comment
Long-term effects on ovarian function remain to be seen.
